Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs DoctorAdam

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and DoctorAdam head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 92 · Grade C

DoctorAdam

Visit DoctorAdam Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 75 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make DoctorAdam a bad call — it's best for people willing to obtain written medication, membership and renewal terms before choosing a starting-price offer. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
78
Transparency
90
88
Access Breadth
93
86
Clinical Oversight
92
84
Track Record
88
80
CoreAge RxBrief Score 94 · 75DoctorAdam

Price, coverage & the tracker

CoreAge RxDoctorAdam
Brief Score94/100 (A)75/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm full recurring charge

Earlier starting quote: $129/mo. Product copy and membership terms differ on added fees.

Full price details

Compounded semaglutide offered. Current medication quote unknown; earlier observed $129/mo starting dose; current product page and membership terms conflict on extra fees

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm full recurring charge

Earlier starting quote: $229/mo. Product copy and membership terms differ on added fees.

Full price details

Current medication quote unknown; earlier observed $229/mo starting dose; current product page and membership terms conflict on extra fees

CoverageUS only; restrictions by state, confirmed at intakeCoverage statements differ; confirm eligibility for the prescribed product and your state
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

DoctorAdam: Injection pages advertise $129/$229 starting prices and no membership, but terms describe recurring membership fees. Confirm the full quote, governing terms and state access.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.